0001567619-20-009229.txt : 20200507
0001567619-20-009229.hdr.sgml : 20200507
20200507171529
ACCESSION NUMBER: 0001567619-20-009229
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200310
FILED AS OF DATE: 20200507
DATE AS OF CHANGE: 20200507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chow Gregory K.
CENTRAL INDEX KEY: 0001761333
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32001
FILM NUMBER: 20857612
MAIL ADDRESS:
STREET 1: C/O APTOSE BIOSCIENCES INC.
STREET 2: 251 CONSUMERS ROAD, SUITE 1105
CITY: TORONTO
STATE: A6
ZIP: M2J 4R3
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptose Biosciences Inc.
CENTRAL INDEX KEY: 0000882361
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 251 CONSUMERS ROAD
STREET 2: SUITE 1105
CITY: TORONTO
STATE: A6
ZIP: M2J 4R3
BUSINESS PHONE: 647-479-9828
MAIL ADDRESS:
STREET 1: 251 CONSUMERS ROAD
STREET 2: SUITE 1105
CITY: TORONTO
STATE: A6
ZIP: M2J 4R3
FORMER COMPANY:
FORMER CONFORMED NAME: Aptose Biosciences Inc., (formerly LORUS THERAPEUTICS INC.)
DATE OF NAME CHANGE: 20140905
FORMER COMPANY:
FORMER CONFORMED NAME: LORUS THERAPEUTICS INC
DATE OF NAME CHANGE: 19990308
FORMER COMPANY:
FORMER CONFORMED NAME: IMUTEC PHARMA INC
DATE OF NAME CHANGE: 19970113
4/A
1
doc1.xml
FORM 4/A
X0306
4/A
2020-03-10
2020-03-12
0
0000882361
Aptose Biosciences Inc.
APTO
0001761333
Chow Gregory K.
C/O APTOSE BIOSCIENCES INC.
251 CONSUMERS ROAD, SUITE 1105
TORONTO
A6
M2J 4R3
ONTARIO, CANADA
0
1
0
0
Executive VP & CFO
Common Shares
2020-03-10
4
A
0
225000
0
A
359514
D
Restricted stock units previously granted with original vesting date of June 10, 2020, shall now vest on July 10, 2020.
/s/ Janet Clennett as attorney-in-fact for Greg Chow
2020-05-07